Influence of the JAK2-V617F mutation on integrin-mediated adhesion to VCAM1 in murine and human cell lines in the context of classical Philadelphia-negative myeloproliferative neoplasms
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Magdeburg, Otto-von-Guericke-Universität Magdeburg, Dissertation, 2019
- Schlagwort
-
Adhesion
Tumors
Cell lines
- Ereignis
-
Veröffentlichung
- (wo)
-
Magdeburg
- (wer)
-
Universitätsbibliothek Otto-von-Guericke-Universität
- (wann)
-
2019
- Urheber
-
Saalfeld, Felix Carl
- Beteiligte Personen und Organisationen
- DOI
-
10.25673/13998
- URN
-
urn:nbn:de:gbv:ma9:1-1981185920-141274
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Saalfeld, Felix Carl
- Schraven, Burkhart
- Koschmieder, Steffen
- Universitätsbibliothek Otto-von-Guericke-Universität
Entstanden
- 2019
Ähnliche Objekte (12)
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives
Kidney dysfunction is associated with thrombosis and disease severity in myeloproliferative neoplasms: implications from the German study group for MPN bioregistry
Regulation of lipocalin 2 expression and function in BCR-ABL- and JAK2V617F-positive myeloproliferative neoplasms
Novel approaches in myelofibrosis
Serum of myeloproliferative neoplasms stimulates hematopoietic stem and progenitor cells
Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms
Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms
An iPSC-derived myeloproliferative neoplasm model to study the role of CALR frameshift mutation zygosity and efficacy of telomerase inhibition
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Myeloproliferative neoplasms: The era of JAK2 mutations and more…
Exploiting Synthetic lethality between Germline BRCA1 haploinsufficiency and PARP inhibition in JAK2V617F-positive myeloproliferative neoplasms
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives
Kidney dysfunction is associated with thrombosis and disease severity in myeloproliferative neoplasms: implications from the German study group for MPN bioregistry
Regulation of lipocalin 2 expression and function in BCR-ABL- and JAK2V617F-positive myeloproliferative neoplasms
Novel approaches in myelofibrosis
Serum of myeloproliferative neoplasms stimulates hematopoietic stem and progenitor cells
Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms
Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms
An iPSC-derived myeloproliferative neoplasm model to study the role of CALR frameshift mutation zygosity and efficacy of telomerase inhibition
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Myeloproliferative neoplasms: The era of JAK2 mutations and more…
Exploiting Synthetic lethality between Germline BRCA1 haploinsufficiency and PARP inhibition in JAK2V617F-positive myeloproliferative neoplasms
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives
Kidney dysfunction is associated with thrombosis and disease severity in myeloproliferative neoplasms: implications from the German study group for MPN bioregistry
Regulation of lipocalin 2 expression and function in BCR-ABL- and JAK2V617F-positive myeloproliferative neoplasms
Novel approaches in myelofibrosis
Serum of myeloproliferative neoplasms stimulates hematopoietic stem and progenitor cells
Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms
Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms
An iPSC-derived myeloproliferative neoplasm model to study the role of CALR frameshift mutation zygosity and efficacy of telomerase inhibition
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Myeloproliferative neoplasms: The era of JAK2 mutations and more…